Jing‐Quan Zheng

<scp>AIM2</scp> upregulation promotes metastatic progression and <scp>PD‐L1</scp> expression in lung adenocarcinoma

Jing‐Quan Zheng, Che‐Hsuan Lin, H Lee et al. · Cancer Science · 2022 · 25 citations · Full text

Metastatic Progression, Pd-l1 Expression, Medicine +14

Lactotransferrin Downregulation Serves as a Potential Predictor for the Therapeutic Effectiveness of mTOR Inhibitors in the Metastatic Clear Cell Renal Cell Carcinoma without PTEN Mutation

Jing‐Quan Zheng, Che-Hsuan Lin, Hsun‐Hua Lee et al. · Biomedicines · 2021 · 14 citations · Full text

Urology, Mtor Inhibitors, Genitourinary Cancer +15

Clinical Experience with Ropeginterferon Alfa-2b in the Off-Label Use for the Treatment of COVID-19 Patients in Taiwan

Kuan-Yuan Chen, Kang‐Yun Lee, Albert Qin et al. · Advances in Therapy · 2021 · 10 citations · Full text

Ropeginterferon Alfa-2b, Covid-19 Pandemic, Clinical Trials +5